Qiming Corporate GP VI, Ltd., 10% Owner at Alamar Biosciences, Inc. (ALMR), sold 342,626 shares at $29.01 ($10.3M) on 2026-10-21, disclosed to the SEC on 2026-10-23.
Open-market sale of $10.3M ALMR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.01 | 22,020 | $639K | 6.2% |
| 2 | $29.01 | 6,151 | $178K | 1.7% |
| 3 | $29.01 | 592 | $17K | 0.2% |
| 4 | $29.01 | 5,138 | $149K | 1.5% |
| 5 | $29.75 | 7,033 | $209K | 2.0% |
| 6 | $29.75 | 677 |
| $20K |
| 0.2% |
| 7 | $29.75 | 5,875 | $175K | 1.7% |
| 8 | $29.75 | 25,177 | $749K | 7.3% |
| 9 | $30.79 | 2,380 | $73K | 0.7% |
| 10 | $30.79 | 88,434 | $2.7M | 26.6% |
| 11 | $30.79 | 24,704 | $761K | 7.4% |
| 12 | $30.79 | 20,634 | $635K | 6.2% |
| 13 | $29.00 | 46,290 | $1.3M | 13.1% |
| 14 | $29.00 | 1,246 | $36K | 0.4% |
| 15 | $29.00 | 10,800 | $313K | 3.1% |
| 16 | $29.00 | 12,931 | $375K | 3.7% |
| 17 | $29.59 | 36,941 | $1.1M | 10.7% |
| 18 | $29.59 | 8,620 | $255K | 2.5% |
| 19 | $29.59 | 994 | $29K | 0.3% |
| 20 | $29.59 | 10,319 | $305K | 3.0% |
| 21 | $30.81 | 1,029 | $32K | 0.3% |
| 22 | $30.81 | 3,683 | $113K | 1.1% |
| 23 | $30.81 | 859 | $26K | 0.3% |
| 24 | $30.81 | 99 | $3K | 0.0% |
| Total | $29.93 avg | 342,626 | $10.3M | 100% |
| Filing → |